A company has announced that an experimental gene therapy has shown promise in slowing the progression of Huntington's disease. Some reports suggest a significant reduction in disease progression, with a 75% reduction cited in several outlets, although the details of the trial and its results are not universally specified. The therapy has been described as a potential breakthrough and a groundbreaking treatment for the disease.